Anticholinergic Medications and Health in Adults with Autism or Intellectual Disability

Objective: Contributors to autistic adults' elevated risk for negative aging-related outcomes, including Alzheimer's disease and related dementias (ADRD), falls, and mortality remain underexplored. One candidate factor is exposure to medications with anticholinergic (AC) effects. Thus, this study assessed prevalence of medications with AC effects, and their associations with ADRD, falls, and mortality across four groups: autism-only, autism+intellectual disability (ID), ID-only, and controls. Methods: We conducted a retrospective cohort study of 2017-2019 US linked Medicare and Medicaid claims

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.